It is also interesting to note that with the advent of Novartis trial end that we could possibly have news
of IMP701 acting as an antagonist (lag525) and also as an agonist (efti/imp321) in close proximity to
each other....Dare I suggest SITC, 9th November, but wait, there's more, mid December we will have
an update on AIPAC at the San Antonio breast cancer conference.....
That conference could well spell the end of AIPAC or it's rebirth after recent underwhelming data....
Gonna be an interesting 3 months
LAG525 Solid and Hematologic Malignancies trial completed, page-10
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148547 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51809 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |